Insulin Therapy in Type 2 Diabetes: Simple and Not So Simple
Einstein-Montefiore Department of Medicine Grand Rounds - Harold Rifkin, MD Visiting Professor
Thursday, April 7, 2011
8:00 am
Forchheimer 1st Floor Lecture Hall, Einstein
repeated at 12:15 pm
Cherhasky Auditorium, Montefiore
Speaker
Hannele Yki-Järvinen, MD, FRCP
Hannele Yki-Järvinen, MD, FRCP
Professor of Medicine (with tenure)
Department of Medicine, Division of Diabetes
University of Helsinki
Head, Division of Diabetes
Department of Medicine
Helsinki University Central Hospital
Dr. Hannele Yki-Järvinen's research interests include the causes and consequences of insulin resistance in humans, the treatment of type 2 diabetes, and nonalcoholic
fatty liver disease.
She has published 245 original articles in English, 70 reviews, textbook chapters and other articles in English, and has given over 300 invited lectures in 44 countries.
Dr. Yki-Järvinen has won international awards for her research, including the G. B. Morgagni Young Investigator Award, Padova, Italy (1993); the 28th Minkowski Award, European Association for the Study of Diabetes, Istanbul, Turkey (1993); the Anders Jahre Pris, University of Oslo, Oslo, Norway (1995); and the Novartis Award in Diabetes for excellence in patient-oriented research, San Diego, USA (1999).
Post-lecture webcast: www.medicinegr.org.
For access code contact Mildred Rodriguez, mirodrig@montefiore.org.
Objectives
After attending this activity, participants will be able to review:
- Current evidence regarding use of insulin in type 2 diabetes with respect to complications and the regimen used
- Practical issues related to insulin therapy based on pathophysiology of type 2 diabetes
Accreditation
Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.